Organisation paid for research Program year 2025 Source: CMS Open Payments

Adams Clinical Trials

Neither a doctor nor a teaching hospital

Research payments

$3,249,765

5 payments

Through program year 2025, Adams Clinical Trials is reported as receiving $3,249,765 in research payments, across 5 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$2,820,612	2
2024	Research	$429,153	3

Breakdown

Who paid Research payments · program years 2024–2025

E.R. Squibb & Sons, L.L.C. $3,249,765 5 payments

Studies the money was for Research payments · program years 2024–2025

A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) $2,820,612 2 payments
Phase 2 PoC in Early AD Patients - A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer s Disease (TargetT $428,148 1 payment
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease (TargetTau-1) $1,005 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.